11Dec/13

“Lots Of Cheques Donated Bounced” | OJB Jezreel Opens Up to Hip TV about … – Bella Naija

“Lots Of Cheques Donated Bounced” | OJB Jezreel Opens Up to Hip TV about
Bella Naija
OJB Jezreel’s kidney transplant surgery has created a lot of media buzz over the past few months. After series of donations to the cause, the veteran jetted off to India for the critical procedure. Good news! It’s over now and the veteran musician has

and more »

11Dec/13

Innovative Program Doubles Patient Engagement, Cuts Heart Failure … – Virtual-Strategy Magazine (press release)

Innovative Program Doubles Patient Engagement, Cuts Heart Failure
Virtual-Strategy Magazine (press release)
SEATTLE, Dec. 11, 2013 /PRNewswire/ — A San Diego medical group’s disease management program increased patient engagement rates from 28% to 67%, leading to a decline in both hospitalizations and 30-day readmissions for program participants.

and more »

11Dec/13

Idelalisib plus rituximab extended survival in previously treated CLL – Healio

Idelalisib plus rituximab extended survival in previously treated CLL
Healio
NEW ORLEANS — The addition of idelalisib to rituximab significantly extended survival in heavily pretreated patients with relapsed chronic lymphocytic leukemia, according to phase 3 study results presented at the ASH Annual Meeting and Exposition.
Idelalisib/Rituximab Combo Improves Survival in Late-Stage CLLCancer Network
Gileads Pipeline EncouragesZacks.com

all 3 news articles »

11Dec/13

Innovative Program Doubles Patient Engagement, Cuts Heart Failure … – PR Newswire (press release)

Innovative Program Doubles Patient Engagement, Cuts Heart Failure
PR Newswire (press release)
SEATTLE, Dec. 11, 2013 /PRNewswire/ — A San Diego medical group’s disease management program increased patient engagement rates from 28% to 67%, leading to a decline in both hospitalizations and 30-day readmissions for program participants.

and more »

11Dec/13

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS … – GlobeNewswire (press release)

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS
GlobeNewswire (press release)
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in ASERTAA (A Study of Extended Release Tacrolimus in African-Americans) Phase IIIb study of ENVARSUS® (formerly LCP Tacro™) in kidney transplant recipients.

and more »

11Dec/13

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry … – DigitalJournal.com

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry
DigitalJournal.com
Clinical trial report, “Kidney Transplantation Global Clinical Trials Review, H2, 2013″ provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney

and more »